Skip to main content

Table 3 Routine laboratory results

From: Association between autonomic nervous dysfunction and cellular inflammation in end-stage renal disease

 

Controls N = 15

Diabetic HD N = 14

Nondiabetic HD N = 14

All HD N = 28

Creatinine (μmol/l)

71.0 [23.0]

531.0 [298.0]**

887.0 [246.5]***

726.5 [400.5]

Urea (mmol/l)

5.0 [1.5]

18.2 [8.6]***

17.9 [9.3]***

17.9 [8.7]

Cholesterol (mmol/l)

4.9 [1.3]

4.6 [2.2]

4.7 [1.7]

4.6 [1.7]

HbA1c (%)

5.5 [0.4]

5.9 [2.1]

5.5 [0.5]

5.6 [0.8]

CRP (mg/l)

1.6 [2.4]

12.6 [9.6]***

4.8 [13.0]

9.4 [12.9]

IL-6 (pg/ml)

1.1 [1.1]

9.7 [12.8]***

4.7 [6.7]**

6.9 [12.6]

Bicarbonate (mmol/l)

25.9 [3.5]

22.8 [1.7]*

22.2 [3.9]**

22.3 [2.6]

BNP (pg/ml)

26.0 [35.0]

287.0 [695.8]***

113.0 [420.8]**

262.0 [401.3]

  1. In some individuals, CRP levels were reported by the lab as < 1 mg/l and IL-6 levels as < 0.5 pg/ml. These data points were entered as 0.5 mg/l and 0.3 pg/ml, respectively.
  2. * = p < 0.05 vs. controls; ** = p < 0.01 vs. controls; *** = p < 0.001 vs. controls by Kruskal-Wallis and Dunn’s test. Statistical tests were done for the three groups controls, diabetic and nondiabetic patients. The column “all HD” remained untested